Bioequivalence Evaluation of Two Film-Coated Formulations of Valsartan 160 mg

NCT02518451 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Valsartan 160 mg film-coated caplets (test formulation)
DRUG: Valsartan 160 mg film-coated caplets (reference formulation)

Sponsor

Dexa Medica Group